Jean-Francois Baurain Selected Research

Acetylcarnitine (Alcar)

1/2013

A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Francois Baurain Research Topics

Disease

6	Neoplasms (Cancer) 03/2022 - 03/2009
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 03/2009
3	Breast Neoplasms (Breast Cancer) 10/2019 - 11/2011
2	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 01/2013
1	Melanoma (Melanoma, Malignant) 03/2022
1	Central Nervous System Neoplasms 01/2022
1	Astrocytoma (Pilocytic Astrocytoma) 01/2022
1	Uveal melanoma 01/2021
1	Exanthema (Rash) 01/2021
1	Fever (Fevers) 01/2021
1	Necrosis 01/2021
1	Pruritus (Itching) 01/2021
1	Disease Progression 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 10/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019
1	Transitional Cell Carcinoma 10/2019
1	Oligomenorrhea 01/2013
1	Amenorrhea 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2013
1	Headache (Headaches) 11/2011
1	Asthenia 11/2011
1	Pleural Effusion (Pleural Effusions) 11/2011
1	Brain Neoplasms (Brain Tumor) 03/2009

Drug/Important Bio-Agent (IBA)

2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 03/2009
2	ErbB Receptors (EGF Receptor)IBA 11/2011 - 03/2009
1	AntibodiesIBA 03/2022
1	Programmed Cell Death 1 ReceptorIBA 03/2022
1	Immune Checkpoint InhibitorsIBA 03/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	tebentafuspIBA 01/2021
1	pembrolizumabIBA 01/2021
1	IpilimumabIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	LTX-315IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	CytokinesIBA 01/2021
1	brivanibIBA 10/2019
1	Bevacizumab (Avastin)FDA Link 03/2015
1	Epothilones (Epothilone)IBA 01/2013
1	Tamoxifen FDA LinkGeneric 01/2013
1	sagopiloneIBA 01/2013
1	Biological ProductsIBA 01/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	Acetylcarnitine (Alcar)IBA 01/2013
1	Tyrosine Kinase InhibitorsIBA 11/2011
1	Dasatinib (BMS 354825)FDA Link 11/2011
1	Pharmaceutical PreparationsIBA 11/2011
1	Hormones (Hormone)IBA 11/2011
1	epidermal growth factor receptor VIIIIBA 03/2009
1	Carmustine (FIVB)FDA Link 03/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2009

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2013 - 11/2011
1	Immunotherapy 03/2022
1	Radiotherapy 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Injections 01/2021
1	Castration 01/2013